At the Growth Asia Summit 2026, Angel Yeast showcased its cutting-edge yeast protein innovations, positioning microbial protein as a vital solution for global food security and nutrition.

Key Takeaways

  • Angel Yeast presented its advanced yeast protein portfolio at the Growth Asia Summit 2026 in Singapore.
  • The flagship product, AngeoPro, is China's first approved microbial protein ingredient with over 80% protein content.
  • A new manufacturing facility in Indonesia is slated to begin operations in 2027 to boost Southeast Asian supply.
  • The shift toward functional, 'on-the-go' protein formats is driving massive growth in the Asia-Pacific market.

During the prestigious Growth Asia Summit 2026 held in Singapore, industry leader Angel Yeast (SSE: 600298) took center stage to showcase the future of sustainable nutrition. On a day dedicated to active lifestyles and health innovation, Chen Zhixian, General Manager of the Nutrition and Health Technology Center, detailed the company's significant strides in yeast protein R&D and its diverse application spectrum.

Addressing the Global Protein Gap

The summit highlighted a critical shift in global dietary patterns. Citing data from the Chinese Center for Disease Control and Prevention, industry experts noted a concerning trend: while total protein intake remains steady, the reliance on animal protein is rising, while plant-based legume proteins are declining. This imbalance, coupled with the fact that nearly 45% of certain populations suffer from protein deficiency, underscores an urgent need for alternative sources. Angel Yeast views the development of microbial proteins not merely as a market opportunity, but as a strategic necessity for long-term global food security.

The AngeoPro Advantage

At the heart of Angel Yeast's innovation is AngeoPro, the first microbial protein ingredient approved in China. Boasting a protein content exceeding 80%, AngeoPro is a versatile powerhouse available in soluble, gel, and dispersible forms. With a perfect PDCAAS score of 1.0, it serves as a complete protein, making it ideal for sports nutrition, elderly supplements, bakery goods, and dairy alternatives. Ongoing research continues to validate its benefits for muscle recovery, immunity, and metabolic regulation.

Strategic Expansion in Asia-Pacific

The Asia-Pacific region is witnessing a massive pivot toward functional nutrition, with consumers demanding convenient, 'snackable' protein formats like protein bars, shakes, and fortified cereals. To capitalize on this and address nutrient gaps in markets like India and Southeast Asia, Angel Yeast has announced plans for a new manufacturing facility in Indonesia. Expected to be operational by 2027, this facility will significantly optimize logistics, reduce tariffs, and shorten lead times across the region, cementing the company's role in the global protein transformation.